Pulmonary Effects of 100% Biodiesel Exhaust
- Conditions
- Inflammation
- Interventions
- Other: Bronchoscopy
- Registration Number
- NCT02690571
- Lead Sponsor
- Umeå University
- Brief Summary
Air pollution is a global environmental and health concern, contributing to onset and deterioration of respiratory and cardiovascular diseases. As climate change and dependence on diminishing fossil fuel supplies have taken center stage in political and scientific debates, renewable carbon-neutral fuels like biodiesel receive increasing attention. The most common biodiesel within the European Union, rapeseed oil methyl ester (RME) is perceived to be a "green fuel", as it is sustainable and of biological origin, and therefore is often predicted to be less harmful to human health. Whilst replacing petrodiesel with biodiesel may have advantageous ecological impacts, consequences to respiratory health remained largely unexplored.
The purpose of the current study is to evaluate whether inhalation of 100% RME biodiesel exhaust would result in an acute airway inflammatory response in healthy human subjects, as shown previously following exposure to petrodiesel exhaust.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Normal ECG
Normal Lung function
Normal Blood samples
Smoking
Pre-existing metabolomic, respiratory and cardiovascular disease
Exposure to high levels of pollutants in occupation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Filtered air exposure Bronchoscopy One hour exposure to filtered air during intermittent exercise in controlled chamber, 6 hours after exposure bronchoscopy is performed. Biodiesel exhaust exposure Bronchoscopy One hour exposure to biodiesel exhaust (generated at same running conditions as earlier studies with diesel exhaust at approximate particle matter concentration 300 mcg/m3) during intermittent exercise in controlled chamber. Six hours after exposure bronchoscopy is performed.
- Primary Outcome Measures
Name Time Method Cytokines in Bronchial wash (BW) 6 hours Bronchial wash (BW) collected by bronchoscopy will be analyzed for cytokines (%).
Cell counts in Bronchial Wash 6 hours Bronchial wash (BW) collected by bronchoscopy will be analyzed for inflammatory cell counts (cells/ml).
- Secondary Outcome Measures
Name Time Method Oxylipin Metabolomic profiling Baseline, 2 hours, 6 hours, 24 hours Metabolomic testing done with mass spectrometry on blood samples, BW and BAL.
Inflammation in bronchoalveolar lavage (BAL) 6 hour BAL collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/ml).
Inflammation in endomucosal biopsies 6 hours Biopsies collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/mm2).